Alex P. Hamilton - 28 Jul 2026 Form 4 Insider Report for MANGOCEUTICALS, INC. (MGRX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Oct 2026, 08:00:17 UTC
Prior SEC filing
26 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alex P. Hamilton

Key filing fact

Alex P. Hamilton filed Form 4 for MANGOCEUTICALS, INC. (MGRX) on 06 Oct 2026.

Key facts

  • This page summarizes Alex P. Hamilton's Form 4 filing for MANGOCEUTICALS, INC. (MGRX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Oct 2026, 08:00.

Change

  • Previous filing in this sequence was filed on 26 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001970448 Primary reporting owner

Hamilton Alex P.

Relationship
Director
Address
C/O MANGOCEUTICALS, INC., 17130 N. DALLAS PARKWAY, SUITE 240, DALLAS
Signature
/s/ Alex P. Hamilton
Signature date
06 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MGRX transaction

Common Stock

Award

Transaction value
Shares
+100,000
Change %
+5999%
Price
$0.000000*
Shares after
101,667
Date
28 Jul 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

Issued in consideration for services rendered as a member of the Board of Directors.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .